What They List
- Psilocybin Research
- Clinical Trials
- Treatment Resistant Depression Study
Research
COMPASS Pathways
Clinical Trial in London, United Kingdom
COMPASS Pathways is studying investigational COMP360 psilocybin treatment for treatment-resistant depression and other mental health indications. Its official materials describe COMP360 trials, and ClinicalTrials.gov lists COMPASS-sponsored psilocybin studies including NCT05624268.
ResearchClinical Trial
Directory Facts
- Status
- Research Institution
- Price
- Not published
- Hours
- Verify with provider
- License / Record
- Not listed
- Last Verified
- 2026-06-12
Location
London
Source Notes
Company is UK-based with trial sites in multiple countries, including the US.
Source: https://compasspathways.com/; https://compasspathways.com/our-work/comp360-psilocybin-treatment-in-trd/; https://clinicaltrials.gov/study/NCT05624268
MagicMushroomsDirectory does not provide medical, legal, or purchasing advice. Verify current laws, provider status, and eligibility before contacting any listing.